Measuring quality of life in chronic illness: The functional assessment of chronic illness therapy measurement system

被引:175
作者
Cella, D
Nowinski, CJ
机构
[1] Evanston NW Healthcare, Ctr Outcomes Res & Educ, Evanston, IL 60201 USA
[2] Northwestern Univ, Evanston, IL 60201 USA
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 2002年 / 83卷 / 12期
关键词
quality of life; questionnaires; rehabilitation;
D O I
10.1053/apmr.2002.36959
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
We focus on quality of life (QOL) measurement as applied to chronic illness. There are 2 major types of health-related quality of life (HRQOL) instruments-generic health status and targeted. Generic instruments offer the opportunity to compare results across patient and population cohorts, and some can provide normative or benchmark data from which to interpret results. Targeted instruments ask questions that focus more on the specific condition or treatment under study and, as a result, tend to be more responsive to clinically important changes than generic instruments. Each type of instrument has a place in the assessment of HRQOL in chronic illness, and consideration of the relative advantages and disadvantages of the 2 options best drives choice of instrument. The Functional Assessment of Chronic Illness Therapy (FACIT) system of HRQOL measurement is a hybrid of the 2 approaches. The FACIT system combines a core general measure with supplemental measures targeted toward specific diseases, conditions, or treatments. Thus, it capitalizes on the strengths of each type of measure. Recently, FACIT questionnaires were administered to a representative sample of the general population with results used to derive FACIT norms. These normative data can be used for benchmarking and to better understand changes in HRQOL that are often seen in clinical trials. Future directions in HRQOL assessment include test equating, item banking, and computerized adaptive testing.
引用
收藏
页码:S10 / S17
页数:8
相关论文
共 58 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Performance of health-related quality-of-life instruments in a spinal cord injured population [J].
Andresen, EM ;
Fouts, BS ;
Romeis, JC ;
Brownson, CA .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1999, 80 (08) :877-884
[3]  
[Anonymous], ASSESSING MED REHABI
[4]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX - DOES MODE OF ADMINISTRATION AFFECT ITS PSYCHOMETRIC PROPERTIES [J].
BARRY, MJ ;
FOWLER, FJ ;
CHANG, YC ;
LISS, CL ;
WILSON, H ;
STEK, M .
JOURNAL OF UROLOGY, 1995, 154 (03) :1056-1059
[5]  
Baum A, 2001, PSYCHOSOC INTERV, P57
[6]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[7]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[8]   Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[9]   Evaluation of measures used to assess quality of life after stroke [J].
Buck, D ;
Jacoby, A ;
Massey, A ;
Ford, G .
STROKE, 2000, 31 (08) :2004-2010
[10]  
CALHOUN EA, 2000, P AN M AM SOC CLIN, V19, pA446